Judicial Review Of Nucleic Acid-Related Harm.
1. Introduction
Nucleic acid-related harm is an emerging area of legal, constitutional, medical, environmental and scientific concern. It involves injuries, damage, violations of rights or adverse consequences arising from the collection, manipulation, storage, testing, transfer, modification or commercial exploitation of nucleic acids.
Nucleic acids are biological molecules responsible for storing and transmitting genetic information. The two principal forms are:
DNA (Deoxyribonucleic Acid): Carries hereditary genetic information.
RNA (Ribonucleic Acid): Plays an important role in gene expression, protein synthesis and cellular regulation.
Modern biotechnology has created new possibilities for genetic testing, gene therapy, genetic engineering, genome editing, recombinant DNA technology and RNA-based medical treatments.
However, these technologies can also create legal concerns, including:
Unauthorised collection or use of DNA samples.
Genetic privacy violations.
Genetic discrimination.
Unintended genetic mutations.
Harm resulting from experimental gene therapies.
Unauthorised genetic modification of human cells.
Environmental harm from genetically modified organisms.
Commercial exploitation of human genetic material.
Misuse of genetic databases.
Inadequate informed consent in genetic research.
Intergenerational and potentially irreversible biological consequences.
Judicial review of nucleic acid-related harm refers to the power of constitutional courts and other competent judicial bodies to examine whether governmental authorities, regulatory institutions, hospitals, laboratories, research organisations and other legally accountable entities have acted lawfully when dealing with nucleic acids and genetic technologies.
Importantly, Indian law does not recognise a separate, fully developed legal doctrine called the law of nucleic acid-related harm. Instead, such disputes are addressed through constitutional rights, medical negligence, environmental law, biotechnology regulation, privacy law, tort principles and scientific research ethics.
2. Meaning and Nature of Nucleic Acid-Related Harm
Nucleic acid-related harm may be understood through five principal categories.
A. Genetic damage
Genetic damage occurs when DNA or RNA is affected in a manner that produces harmful biological consequences.
Examples include:
DNA strand breaks.
Unintended mutations.
Chromosomal abnormalities.
Genetic instability.
Damage to cellular genetic material.
Unintended changes resulting from genome-editing procedures.
A person alleging genetic damage may seek judicial intervention where the harm results from negligent medical treatment, unsafe experimentation, unlawful industrial activity or regulatory failure.
B. Genetic privacy harm
DNA contains highly personal information concerning biological identity, inherited characteristics and familial relationships.
Unauthorised collection, disclosure, retention or use of genetic information may violate personal privacy.
For example:
A hospital discloses a patient's genetic test results without lawful justification.
An employer uses genetic information to discriminate against an applicant.
A research institution transfers DNA samples to commercial organisations without valid consent.
A government authority retains genetic information without adequate legal safeguards.
C. Genetic manipulation and modification harm
Genetic manipulation involves deliberate changes to genetic material through biotechnology.
Examples include:
CRISPR-based genome editing.
Recombinant DNA technology.
Gene therapy.
Genetically modified organisms.
Experimental genetic interventions.
The principal legal concern is whether the intervention was scientifically justified, properly authorised, ethically conducted and accompanied by appropriate safety measures.
D. Reproductive and hereditary harm
Certain genetic interventions may potentially affect reproductive cells or future generations.
This raises questions involving:
Reproductive autonomy.
Informed consent.
Human dignity.
Genetic inheritance.
Protection of future generations.
Ethical limitations on germline editing.
E. Commercial exploitation of genetic material
Human biological materials may be collected for research and subsequently used to develop commercially valuable discoveries.
Legal questions include whether the original donor was properly informed, whether consent covered subsequent uses and whether researchers breached confidentiality or fiduciary obligations.
3. Constitutional Foundations of Judicial Review in India
The Indian Constitution provides several important protections relevant to nucleic acid-related harm.
A. Article 14 – Right to Equality
Article 14 prohibits arbitrary State action and guarantees equality before the law.
It becomes relevant where governmental authorities:
Approve genetic experiments without rational assessment.
Discriminate against individuals based on genetic characteristics.
Apply genetic testing requirements arbitrarily.
Permit unequal access to genetic medical treatment.
Fail to establish fair regulatory procedures.
A genetic-testing policy that discriminates irrationally between similarly situated individuals may be challenged under Article 14.
B. Article 19 – Freedom and Personal Autonomy
Article 19 protects specified freedoms, subject to constitutionally permissible restrictions.
Genetic information and biotechnology may raise questions involving:
Freedom of scientific research.
Professional autonomy.
Freedom of expression in scientific publication.
Commercial activities relating to biotechnology.
However, scientific freedom does not provide unrestricted authority to conduct dangerous or unauthorised experiments.
C. Article 21 – Right to Life, Liberty, Privacy and Dignity
Article 21 is particularly important.
The right to life has been interpreted broadly to include dignity, bodily integrity, privacy and protection against unlawful interference with personal autonomy.
In genetic disputes, Article 21 may protect:
Bodily integrity against unauthorised genetic procedures.
Confidentiality of genetic information.
Informed medical consent.
Reproductive autonomy.
Protection against unsafe medical experimentation.
Access to a safe and healthy environment.
A person whose genetic information has been unlawfully disclosed may potentially seek constitutional or other legal remedies, depending on the responsible entity and applicable law.
D. Article 32 – Constitutional Remedies
Article 32 enables individuals to approach the Supreme Court for enforcement of fundamental rights.
It may become relevant where governmental action or legally attributable State inaction causes violations involving genetic privacy, bodily autonomy or environmental safety.
E. Article 226 – High Court Jurisdiction
High Courts possess broad writ jurisdiction under Article 226.
They may examine:
Unlawful approvals of genetic experiments.
Arbitrary regulatory decisions.
Failure to exercise statutory powers.
Violations of constitutional rights.
Procedural irregularities in biotechnology regulation.
F. Articles 47 and 48A – Public Health and Environmental Protection
Article 47 directs the State to improve public health.
Article 48A requires the State to protect and improve the environment.
These provisions are important when nucleic acid-related activities create potential risks to human health, biodiversity or ecological stability.
Article 51A(g) also imposes a fundamental duty on citizens to protect and improve the natural environment.
4. Important Indian Case Laws
The following judgments provide the principal legal foundations for judicial review of nucleic acid-related harm.
1. Justice K.S. Puttaswamy (Retd.) v. Union of India (2017) 10 SCC 1
Landmark constitutional judgment
Court: Supreme Court of India
Year: 2017
Facts:
The case concerned the constitutional recognition of privacy as a fundamental right. A nine-judge Constitution Bench considered whether privacy was protected under the Indian Constitution.
Legal principles established:
The Supreme Court recognised privacy as an intrinsic part of Article 21 and other fundamental freedoms.
The judgment recognised privacy interests involving:
Personal information.
Bodily autonomy.
Individual identity.
Personal choices.
Informational privacy.
Human dignity.
Application to nucleic acid-related harm:
Genetic information is particularly sensitive because it can reveal information about an individual's biological identity and family relationships.
Consequently, the Puttaswamy principles may apply to:
Unauthorised DNA collection.
Unlawful genetic database retention.
Disclosure of genetic test results.
Genetic profiling without adequate legal authority.
Commercial exploitation of genetic information.
Discriminatory use of genetic information.
Judicial significance:
The judgment provides a constitutional foundation for challenging unlawful genetic surveillance and misuse of personal genetic information.
It also requires restrictions on privacy to satisfy constitutional standards of legality, legitimate purpose, proportionality and appropriate safeguards.
2. Selvi v. State of Karnataka (2010) 7 SCC 263
Court: Supreme Court of India
Year: 2010
Facts:
The case concerned the involuntary administration of scientific investigative techniques, including:
Narcoanalysis.
Polygraph examination.
Brain Electrical Activation Profile testing.
The petitioners challenged the use of these procedures without their consent.
Legal issues:
Whether involuntary scientific testing violates Article 20(3).
Whether compulsory procedures violate Article 21.
Whether bodily and mental privacy must be protected.
Whether scientific investigation can override individual autonomy.
Judgment:
The Supreme Court held that the involuntary administration of the impugned techniques violates Articles 20(3) and 21.
It emphasised personal liberty, bodily integrity, mental privacy and the importance of consent.
Application to nucleic acid-related harm:
Although Selvi did not directly decide the legality of genetic manipulation, its constitutional reasoning is relevant to compulsory genetic procedures.
For example, a person may challenge an unlawful genetic intervention involving the extraction or manipulation of biological material.
However, the distinction between testimonial evidence and physical evidence is important: Selvi did not prohibit all compulsory collection of DNA evidence.
Legal significance:
The judgment establishes that scientific advancement cannot automatically override constitutional protections.
3. Sharda v. Dharmpal (2003) 4 SCC 493
Court: Supreme Court of India
Year: 2003
Facts:
The dispute arose in matrimonial proceedings where one party sought a medical examination of the other.
Legal issue:
Whether a court can direct a medical examination despite an individual's objection based on privacy.
Judgment:
The Supreme Court recognised that privacy is important but not absolute.
A court may direct a medical examination where sufficient grounds exist and the examination is necessary for resolving the dispute.
Application to nucleic acid-related harm:
This case is relevant to compulsory DNA testing and genetic examinations.
A court considering a DNA test should evaluate:
Whether the test is genuinely necessary.
Whether relevant evidence is otherwise available.
Whether the intrusion is proportionate.
Whether the interests of children or other affected persons require consideration.
Whether privacy and dignity are adequately protected.
Legal significance:
Sharda provides an important framework for balancing the individual's privacy against legitimate judicial requirements.
4. Bhabani Prasad Jena v. Convenor Secretary, Orissa State Commission for Women (2010) 8 SCC 633
Court: Supreme Court of India
Year: 2010
Facts:
The case involved a dispute in which DNA testing was sought to determine biological relationships.
Legal issue:
Whether courts should routinely order DNA tests in disputes concerning parentage.
Judgment:
The Supreme Court held that DNA testing should not be ordered mechanically.
The court must consider the necessity of the test, the available evidence and the competing interests of the parties.
Application to nucleic acid-related harm:
This decision is relevant because DNA testing involves access to highly personal genetic information.
It establishes that genetic testing must have a legitimate judicial purpose and should not be ordered merely because a party requests it.
Legal significance:
It supports judicial protection against unnecessary genetic intrusion.
5. Nandlal Wasudeo Badwaik v. Lata Nandlal Badwaik (2014) 2 SCC 576
Court: Supreme Court of India
Year: 2014
Facts:
The dispute concerned paternity and the evidentiary value of DNA testing.
Legal issue:
Whether DNA evidence could be considered when determining biological paternity in the face of other legal presumptions.
Judgment:
The Supreme Court considered the scientific significance of DNA evidence and its relevance to determining biological parentage.
Application to nucleic acid-related harm:
The case illustrates that DNA testing has substantial evidentiary importance.
However, scientific accuracy does not eliminate the requirement to consider privacy, dignity, procedural fairness and the legal presumptions applicable to the dispute.
Legal significance:
It demonstrates the relationship between scientific evidence and judicial decision-making.
6. Gene Campaign v. Union of India (2024) 2024 INSC 545
Major biotechnology judicial review decision
Court: Supreme Court of India
Decision: 23 July 2024
Facts:
The litigation concerned the regulatory approval and environmental release of genetically modified crops, including genetically modified mustard (DMH-11).
The petitioners raised concerns regarding:
Biosafety.
Environmental risks.
Human health.
Scientific assessment.
Regulatory independence.
The precautionary principle.
Legal issues:
Whether decisions of biotechnology regulatory authorities are subject to judicial review.
Whether genetic engineering approvals comply with statutory requirements.
Whether the precautionary principle applies to genetically modified organisms.
Whether regulatory decisions adequately consider environmental and health risks.
Judgment and important principles:
The two judges expressed differing views on important merits issues relating to the approval of GM mustard.
However, they agreed on the following important propositions:
Decisions of authorities dealing with genetically modified organisms are subject to judicial review.
The Union Government must develop a national policy concerning GM crops, including research, cultivation, trade and commerce.
Application to nucleic acid-related harm:
This is especially relevant because genetic engineering involves deliberate changes to genetic material.
The judgment provides a foundation for challenging biotechnology approvals where authorities fail to comply with legal requirements or disregard relevant safety considerations.
Legal significance:
It confirms that complex scientific and technological decisions are not immune from constitutional judicial scrutiny.
The courts generally review the legality and fairness of the regulatory process rather than substitute their own scientific conclusions for those of competent experts.
API SCI+1
7. Aruna Rodrigues v. Union of India (2012) 5 SCC 331
Court: Supreme Court of India
Year: 2012
Facts:
The petitioners raised concerns regarding the environmental release and field testing of genetically modified organisms.
They argued that inadequate biosafety examination could endanger human health and the environment.
Legal issues:
Whether GMO field trials require appropriate regulatory safeguards.
Whether scientific risk assessment must precede environmental release.
Whether regulatory authorities have fulfilled their statutory responsibilities.
Judgment:
The Supreme Court considered the need for scientific evaluation and regulatory safeguards.
It constituted a Technical Expert Committee to examine biosafety questions, including environmental and health safety assessments.
Application to nucleic acid-related harm:
Genetically modified organisms contain altered genetic material.
The decision therefore provides an important judicial precedent for reviewing potentially harmful consequences arising from genetic engineering.
Legal significance:
It demonstrates the importance of expert assessment, regulatory supervision and preventive safeguards in biotechnology disputes.
Indian Kanoon+1
5. Additional Indian Environmental Law Cases
These decisions are relevant where genetic engineering or other nucleic acid-related activities create environmental risks.
| Case | Citation | Legal principle |
|---|---|---|
| Vellore Citizens' Welfare Forum v. Union of India | (1996) 5 SCC 647 | Precautionary principle and polluter pays principle |
| A.P. Pollution Control Board v. Prof. M.V. Nayudu | (1999) 2 SCC 718 | Scientific uncertainty and environmental decision-making |
| M.C. Mehta v. Union of India | (2004) 12 SCC 118 | Preventive environmental protection |
| Indian Council for Enviro-Legal Action v. Union of India | (1996) 3 SCC 212 | Environmental liability and polluter pays |
| Jacob Puliyel v. Union of India | 2022 SCC OnLine SC 533 | Judicial review of public health policies |
These cases help establish that the State cannot simply ignore potential environmental harm because scientific certainty is unavailable.
The precautionary principle is particularly relevant when genetic engineering creates a scientifically identifiable possibility of serious or irreversible harm.
API SCI+1
6. Important International Case Laws
International decisions provide useful comparative principles concerning genetic material, informed consent, genetic privacy and biotechnology.
1. Moore v. Regents of the University of California (1990) 51 Cal.3d 120
Court: Supreme Court of California, United States
Year: 1990
Facts:
John Moore was treated for hairy-cell leukaemia. His physician used cells removed from his body to develop a commercially valuable cell line without adequately informing him of the research and financial interests involved.
Moore challenged the exploitation of his biological material.
Legal issues:
Whether a patient retains ownership rights over removed biological material.
Whether medical professionals must disclose research and financial interests.
Whether commercial exploitation without informed consent creates legal liability.
Judgment:
The California Supreme Court rejected Moore's conversion claim based on ownership of the removed cells.
However, it recognised that claims involving breach of fiduciary duty and lack of informed consent could proceed.
Application to nucleic acid-related harm:
The case is important where researchers collect DNA or other biological material from patients and subsequently use it for commercial research without adequate disclosure.
Legal significance:
It demonstrates that commercial research involving human genetic material raises important questions of informed consent, professional responsibility and patient autonomy.
2. Greenberg v. Miami Children's Hospital Research Institute (2003) 264 F. Supp. 2d 1064
Court: United States District Court, Southern District of Florida
Year: 2003
Facts:
Families affected by Canavan disease provided tissue samples and other information to support genetic research.
The researcher identified and patented the relevant gene and associated testing technology.
The families alleged that their contributions had been used in ways inconsistent with their expectations.
Legal issues:
Whether researchers can commercially exploit genetic discoveries arising from donated tissue.
Whether donor expectations create enforceable obligations.
Whether unjust enrichment is an appropriate legal remedy.
Judgment:
The court dismissed several claims, including conversion and certain informed-consent claims, but allowed the unjust-enrichment claim to survive.
Application:
The decision is relevant to disputes involving the commercial exploitation of genetic samples and the obligations of research institutions towards donors.
Legal significance:
It highlights the distinction between ownership of biological material, informed consent and unjust enrichment.
3. Association for Molecular Pathology v. Myriad Genetics, Inc. 569 U.S. 576 (2013)
Court: Supreme Court of the United States
Year: 2013
Facts:
Myriad Genetics had isolated and identified the BRCA1 and BRCA2 genes associated with increased risks of breast and ovarian cancer.
The company sought patent protection over isolated genetic sequences.
Legal issue:
Whether naturally occurring human DNA can be patented merely because it has been isolated.
Judgment:
The US Supreme Court held that naturally occurring DNA is not patentable merely because it has been isolated.
However, synthetically created complementary DNA (cDNA) may be patentable, subject to applicable patentability requirements.
Application to nucleic acid-related harm:
The decision is relevant to the regulation of genetic research and commercial control over genetic information.
It helps distinguish naturally occurring genetic material from inventions involving human technical intervention.
Legal significance:
It establishes an important boundary between discoveries of natural genetic material and patentable inventions.
4. R (S) v. Chief Constable of South Yorkshire Police [2004] UKHL 39
Court: House of Lords, United Kingdom
Year: 2004
Facts:
The case concerned the retention of fingerprints and DNA samples taken from individuals who had been arrested but were not convicted.
Legal issue:
Whether indefinite retention of DNA material violated the right to private life under Article 8 of the European Convention on Human Rights.
Judgment:
The House of Lords initially accepted the statutory retention framework.
However, the subsequent European Court of Human Rights decision in S and Marper v. United Kingdom fundamentally changed the legal position.
5. S and Marper v. United Kingdom (2008) 48 EHRR 50
Court: European Court of Human Rights
Year: 2008
Facts:
The applicants challenged the indefinite retention of fingerprints, cellular samples and DNA profiles after criminal proceedings had ended without conviction.
Legal issue:
Whether retaining such personal biological information violated Article 8 of the European Convention on Human Rights.
Judgment:
The European Court held that the blanket and indiscriminate retention of DNA samples and profiles violated the applicants' right to respect for private life.
Application to nucleic acid-related harm:
The judgment is particularly relevant to:
DNA databases.
Genetic profiling.
Indefinite storage of genetic samples.
Retention of genetic information after acquittal.
Privacy and informational autonomy.
Legal significance:
It demonstrates that collecting DNA for a legitimate purpose does not automatically justify unlimited retention or unrestricted future use.
7. Legal Framework Governing Nucleic Acid-Related Harm in India
There is no single comprehensive Indian statute governing every aspect of nucleic acid-related harm. Different laws apply depending on the nature of the activity.
| Legislation | Relevance |
|---|---|
| Constitution of India | Articles 14, 19, 21, 32, 226, 47 and 48A |
| Environment (Protection) Act, 1986 | Regulation of hazardous environmental activities |
| Environment (Protection) Rules, 1986 | Environmental regulatory framework |
| Rules, 1989 under the Environment (Protection) Act | Manufacture, use, import, export and storage of hazardous microorganisms and genetically engineered organisms or cells |
| Biological Diversity Act, 2002 | Conservation of biological diversity and regulation of access to biological resources |
| Food Safety and Standards Act, 2006 | Food safety, including applicable requirements concerning genetically engineered food |
| Indian Medical Council/medical professional regulations | Medical ethics and professional responsibility, as applicable |
| Consumer Protection Act, 2019 | Remedies for qualifying deficiencies in medical services and other consumer transactions |
| Bharatiya Nyaya Sanhita, 2023 | Criminal liability where the facts satisfy applicable offences |
| Digital Personal Data Protection Act, 2023 | Protection of covered digital personal data, subject to its scope and commencement provisions |
| Patents Act, 1970 | Patentability of biotechnology inventions and related exclusions |
A. Environment (Protection) Act, 1986
This legislation is important for controlling environmental risks arising from genetic engineering.
The Central Government has powers to take measures to protect and improve environmental quality.
Under the Environment (Protection) Rules, 1986, the 1989 Rules regulate specified activities involving genetically engineered organisms and hazardous microorganisms.
Relevant authorities include:
Genetic Engineering Appraisal Committee (GEAC).
Review Committee on Genetic Manipulation (RCGM).
Institutional Biosafety Committees (IBSC).
State Biotechnology Coordination Committees.
District-level committees.
Judicial review may be invoked where these authorities fail to follow statutory procedures or ignore relevant biosafety requirements.
B. Rules, 1989: Genetically Engineered Organisms
The Rules of 1989 are particularly important for nucleic acid-related environmental harm.
They regulate activities involving genetically engineered organisms and hazardous microorganisms.
These rules provide a regulatory structure for:
Research involving genetically engineered organisms.
Laboratory handling.
Containment measures.
Field trials.
Environmental release.
Import and export.
Commercial use.
If a research institution or biotechnology company violates applicable biosafety requirements, regulatory and judicial intervention may become necessary.
C. Biological Diversity Act, 2002
The Act is concerned with biodiversity conservation, sustainable use of biological resources and fair and equitable sharing of benefits.
It becomes relevant where genetic resources are collected, researched or commercially utilised.
It may also be relevant to disputes involving genetic resources derived from plants, microorganisms and other biological materials.
D. Digital Personal Data Protection Act, 2023
Genetic information stored digitally may fall within the definition of personal data when it relates to an identifiable individual.
Its protection depends on the statutory scope, applicable provisions, commencement and exemptions.
It is important to distinguish the protection of digital genetic information from the regulation of the physical DNA sample itself.
8. Grounds for Judicial Review of Nucleic Acid-Related Harm
Judicial review may be sought on several grounds.
1. Illegality
Illegality arises when a public authority acts contrary to the Constitution, legislation or applicable regulations.
Examples:
Approval of an unauthorised genetic experiment.
Violation of biosafety rules.
Unlawful disclosure of genetic information.
Failure to comply with statutory research requirements.
A court may invalidate the decision or direct the authority to act according to law.
2. Procedural impropriety
A decision may be challenged when mandatory procedures are ignored.
Examples include:
Failure to obtain required regulatory approvals.
Failure to conduct mandatory risk assessments.
Failure to follow prescribed biosafety protocols.
Failure to provide a fair hearing where required.
Failure to comply with applicable informed-consent requirements.
3. Irrationality and arbitrariness
An administrative decision may be invalidated where it is manifestly arbitrary, irrational or unsupported by relevant considerations.
For example, approving a genetic intervention without considering important scientific evidence may invite judicial scrutiny.
4. Violation of fundamental rights
A nucleic acid-related activity may violate Article 21 where it involves:
Unauthorised bodily intervention.
Unlawful disclosure of genetic information.
Disproportionate genetic surveillance.
Arbitrary interference with reproductive autonomy.
Discrimination involving State action.
5. Failure to apply the precautionary principle
This ground is especially important in genetic engineering.
Where a proposed activity presents a credible threat of serious or irreversible environmental harm, the State cannot automatically disregard the risk merely because scientific uncertainty remains.
The precautionary principle requires appropriate preventive action based on scientifically supported risk concerns.
6. Lack of proportionality
A genetic intervention or testing requirement should not impose an unnecessarily excessive restriction on individual rights.
For example, collecting and indefinitely retaining DNA from every individual may raise serious proportionality concerns.
The reviewing court considers whether the interference is lawful, necessary and appropriately safeguarded.
7. Mala fide exercise of power
Where regulatory authorities act for improper purposes, favour particular commercial interests or deliberately disregard statutory obligations, their decisions may be challenged.
9. Application of Judicial Review to Different Types of Nucleic Acid-Related Harm
A. DNA damage and mutation
Courts may examine whether genetic damage resulted from negligent treatment, unsafe experimentation or unlawful exposure to hazardous substances. Medical evidence and expert testimony are essential.
CRISPR-Cas9: Transformations in Gene Editing | AmBioTech
B. Genome-editing harm
Courts may examine whether the intervention had proper approval, adequate safety testing, informed consent and appropriate monitoring.
C. Genetic privacy violations
Courts may examine unauthorised collection, disclosure, retention and use of DNA samples and genetic profiles.
Nuevo marco regulatorio abre camino a la edición génica en investigación agrícola - Redagrícola
D. Genetically modified organism harm
Judicial review may examine environmental approval, biosafety assessment, scientific independence and regulatory compliance.
Medical illustration of messenger RNA or mRNA molecule.
E. RNA-based treatment harm
Courts may examine adverse treatment outcomes, clinical-trial safeguards, medical negligence, informed consent and product liability where legally established.
10. Judicial Remedies Available for Nucleic Acid-Related Harm
Depending on the facts, the nature of the defendant and the applicable legislation, courts may provide several remedies.
A. Constitutional writ remedies
Under Articles 32 and 226, constitutional courts may issue:
Mandamus: Directing a public authority to perform its legal duties.
Certiorari: Quashing an unlawful administrative or regulatory decision.
Prohibition: Preventing an authority from proceeding beyond its jurisdiction.
Habeas Corpus: Protecting personal liberty against unlawful detention.
Quo Warranto: Examining the legal authority by which a person holds a public office.
B. Injunctions
Courts may grant temporary or permanent injunctions to prevent:
Unauthorised genetic experimentation.
Unlawful disclosure of genetic information.
Unsafe environmental release of genetically modified organisms.
Continued use of biological samples in violation of applicable legal obligations.
C. Compensation and damages
Compensation may be available where a legally recognised cause of action is established.
Potential claims include:
Medical negligence.
Breach of confidentiality.
Breach of informed consent.
Violation of constitutional rights by State authorities.
Environmental damage.
Deficiency in medical services.
Product liability, where applicable.
D. Environmental restoration
Where genetically engineered organisms or other biotechnology activities cause environmental damage, appropriate authorities and courts may order:
Environmental restoration.
Remediation.
Monitoring.
Scientific investigation.
Compensation for environmental damage.
Preventive safeguards.
E. Regulatory directions
Courts may direct regulatory bodies to:
Conduct independent scientific assessments.
Reconsider defective approvals.
Improve biosafety protocols.
Establish monitoring mechanisms.
Protect genetic information.
Ensure compliance with statutory requirements.
11. Evidence Required to Establish Nucleic Acid-Related Harm
Scientific evidence is particularly important because an allegation of genetic damage does not automatically establish legal liability.
The claimant must ordinarily establish the relevant elements of the legal claim.
| Evidence | Legal relevance |
|---|---|
| DNA sequencing reports | Identification of genetic changes |
| RNA analysis | Evidence of changes in gene expression |
| Chromosomal analysis | Identification of chromosomal abnormalities |
| Medical records | Evidence of clinical injury |
| Genetic testing reports | Identification of genetic characteristics |
| Laboratory records | Examination of experimental procedures |
| Consent documents | Whether valid informed consent was obtained |
| Expert testimony | Scientific explanation and causation |
| Regulatory approvals | Whether the activity complied with applicable law |
| Environmental assessment | Evaluation of ecological consequences |
The importance of causation
A claimant must distinguish between:
A genetic variation that existed naturally.
A mutation resulting from an external intervention.
A genetic change that produces no clinical injury.
A genetic change that causes a demonstrable adverse consequence.
For example, merely identifying a DNA mutation does not establish that a particular medical procedure caused it.
Scientific causation, legal causation and actual injury must be assessed separately.
12. Burden of Proof and Scientific Uncertainty
The burden of proof depends on the nature of the proceedings.
In medical negligence cases: The claimant ordinarily must establish the applicable duty, breach, causation and injury.
In constitutional proceedings: The petitioner must establish the relevant infringement or unlawful State action.
In environmental proceedings: The precautionary principle and statutory environmental framework may affect the allocation of evidentiary responsibilities.
In Vellore Citizens' Welfare Forum v. Union of India (1996) 5 SCC 647, the Supreme Court recognised that the precautionary principle and polluter pays principle form part of Indian environmental law.
This is significant because genetic engineering may involve uncertainties concerning long-term environmental effects.
However, the precautionary principle does not mean that every allegation of genetic risk automatically establishes liability or requires a complete prohibition.
Courts must consider the credibility of the scientific evidence, seriousness of the potential harm and applicable regulatory framework.
13. Limitations of Judicial Review
Judicial review of nucleic acid-related harm has certain limitations.
A. Lack of scientific expertise
Courts are not scientific laboratories and cannot independently determine complex molecular biology questions without appropriate expert assistance.
B. Difficulty in proving causation
Genetic changes may arise from several factors, making it difficult to establish whether a particular intervention caused the alleged injury.
C. Conflict between scientific innovation and safety
Excessive restrictions may interfere with beneficial medical research, while inadequate safeguards may expose individuals and the environment to unacceptable risks.
D. Absence of comprehensive genetic legislation
India does not have one comprehensive statute governing every aspect of human genetic privacy, genome editing, genetic discrimination and genetic research.
E. Difficulty of determining long-term consequences
Certain genetic interventions may have consequences that become apparent only after extended periods.
These limitations make expert committees, independent scientific assessments and continuing regulatory supervision particularly important.
14. Important Legal Principles Emerging from the Case Laws
| Legal principle | Leading judgment |
|---|---|
| Genetic and informational privacy | Puttaswamy (2017) |
| Bodily integrity and consent | Selvi (2010) |
| Necessity of medical examination | Sharda (2003) |
| Limits on compulsory DNA testing | Bhabani Prasad Jena (2010) |
| Evidentiary value of DNA testing | Nandlal Wasudeo Badwaik (2014) |
| Judicial review of genetic engineering decisions | Gene Campaign (2024) |
| Biosafety and regulatory safeguards | Aruna Rodrigues (2012) |
| Commercial exploitation of human tissue | Moore (1990) |
| Genetic research and unjust enrichment | Greenberg (2003) |
| Patentability of naturally occurring DNA | Myriad Genetics (2013) |
| DNA retention and privacy | S and Marper (2008) |
| Precautionary principle | Vellore Citizens (1996) |
15. Suggested Structure for a Judicial Review Petition
A petition concerning nucleic acid-related harm may be organised under the following headings:
Parties: Identification of the petitioner and respondent authorities.
Facts: Description of the genetic procedure, research, testing or alleged harm.
Nature of injury: Explanation of the physical, genetic, psychological, privacy-related or environmental consequences.
Constitutional violations: Identification of relevant fundamental rights.
Statutory violations: Identification of applicable biotechnology, medical or environmental provisions.
Scientific evidence: Medical reports, laboratory findings and expert opinions.
Grounds for review: Illegality, arbitrariness, procedural impropriety, disproportionality or failure to apply precautionary safeguards.
Relevant precedents: Citation of the applicable Supreme Court and comparative judgments.
Reliefs sought: Compensation, injunction, reconsideration of approval, restoration or regulatory directions.
16. Conclusion
Judicial review of nucleic acid-related harm represents an important intersection between constitutional law, biotechnology, medical jurisprudence, environmental protection and human rights.
The Indian constitutional framework provides protection through Articles 14, 19 and 21, while Articles 32 and 226 enable judicial enforcement of fundamental rights.
The most important principles emerging from the case law are:
Privacy: Genetic information deserves meaningful protection against unlawful collection and disclosure.
Consent: Scientific and medical interventions must respect applicable requirements of informed consent.
Bodily integrity: Genetic procedures cannot automatically override individual autonomy.
Scientific accountability: Biotechnology regulatory authorities must follow lawful and scientifically defensible procedures.
Precaution: Serious environmental risks must be addressed even where complete scientific certainty is unavailable.
Proportionality: Restrictions on individual rights must be legally justified and appropriately limited.
Remedial justice: Persons suffering legally established harm may seek compensation, injunctions and other appropriate remedies.
The central legal proposition is that scientific advancement does not operate outside constitutional and statutory control. Genetic technologies must remain subject to legality, informed consent, privacy, scientific accountability, environmental responsibility and judicial supervision.
17. Important References for Further Legal Research
The following primary judgments are particularly useful for academic writing, examinations and legal research.
Selvi v. State of Karnataka (2010) – Supreme Court judgment.
Gene Campaign v. Union of India (2024) – Official Supreme Court judgment.
Aruna Rodrigues v. Union of India (2012).
Moore v. Regents of the University of California (1990).
Greenberg v. Miami Children's Hospital (2003).
Supreme Court judgment discussing DNA evidence and constitutional protections.
Academic note: For a legal dissertation, the strongest approach is to distinguish direct genetic-material decisions from analogous constitutional and environmental precedents. In particular, Gene Campaign, Puttaswamy, Selvi, Moore and S and Marper together provide a useful foundation for analysing the judicial control of nucleic acid-related harm.
RELATED Blog
comments